SCHEMBL29469870

SCHEMBL29469870

Cc1ncccc1S(=O)(=O)NC(=O)c1cc2c(F)cc(N3CCC3)cc2o1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DCTPP1 Q9H773 1/20 0.37
KMT2A Q03164 6/20 0.35
MEN1 O00255 4/20 0.35
TDP1 Q9NUW8 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
MAPT P10636 3/20 0.34
ALDH1A1 P00352 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
COMT P21964 2/20 0.34
MAPK1 P28482 1/20 0.34
ATM Q13315 1/20 0.34
GFER P55789 2/20 0.33
TP53 P04637 2/20 0.33
GAA P10253 2/20 0.33
TSHR P16473 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
USP2 O75604 1/20 0.33
LDHA P00338 1/20 0.32
PDE4B Q07343 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24333372 1.00 DCTPP1 (0.37) DCTPP1KMT2AMEN1TDP1RXFP1
SCHEMBL24333797 0.87 GFER (0.37) KMT2AALDH1A1NPC1RAB9ACOMT
SCHEMBL29469855 0.87 GFER (0.37) KMT2AALDH1A1NPC1RAB9ACOMT
SCHEMBL29469702 0.85 DRD2 (0.35) KMT2ARXFP1MAPTALDH1A1GFER
SCHEMBL24334212 0.85 CCKBR (0.42) GFER
SCHEMBL24333991 0.85 KMT2A (0.33) KMT2AMEN1TDP1RXFP1MAPT
SCHEMBL29469818 0.85 KMT2A (0.33) KMT2AMEN1TDP1RXFP1MAPT
SCHEMBL29469648 0.84 KMT2A (0.36) KMT2AMEN1TDP1RXFP1MAPT
SCHEMBL24333957 0.84 S1PR3 (0.33) KMT2AMEN1TDP1RXFP1MAPT
SCHEMBL29469656 0.84 S1PR3 (0.33) KMT2AMEN1TDP1RXFP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed